These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Other||2019-000951-14||A Phase 2, Double-Blind, Placebo Controlled Study of RV001V in Men with Biochemical Failure following Curatively Intended Therapy for Localized Prostate Cancer||not-yet-due|
|Ongoing||2020-004705-31||Long-term follow-up study of immune response to vaccinations with RV001 in patients enrolled in RhoVac-001 study||not-yet-due|